Back to search

Peptide record

TPDB41170

Cationic Amphiphilic Anticancer standard
16 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB41170
Cationic Amphiphilic
Anticancer
Cancer-related peptides
AntiCP 2.0 CancerPPD 2.0 Peptipedia SATPdb dbACP iACP-DRLF
standard
No
A 16-aa standard natural anticancer peptide sequence curated from AntiCP 2.0, CancerPPD 2.0, Peptipedia, and other sources, with an available 3D structural model.
Sequence
GIIKKIIIKKIIIKKI
Physicochemical Analysis
C92H176N22O17
ARNDCEQHLMFPSTWYV
I
1862.55
11.21
6
0
9
+6
3.16
1.044
219.38
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
0
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
9
I
0
L
6
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 9 L: 0 K: 6 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
16
C92H176N22O17
1862.55
11.21
+6
3.16
1.044
Free
L
Cyclic
Free
Antimicrobial
AMP
Evidence Records 2 records
Evidence 1 Activity

Activity

IC50
IC50 = 15 µM
Anticancer
15 µM

Target

Cervical Cancer
HeLa
Cervix

Assay & Model

WST-1 assay
Not Available

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2011

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50 = 25 µM
Anticancer
25 µM

Target

Pancreatic Cancer
HL-60
Pancreatic

Assay & Model

WST-1 assay
Not Available

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2011